Virologic, hematologic, and immunologic risk factors for classic Kaposi sarcoma

Classic Kaposi sarcoma (CKS) is an inflammatory‐mediated neoplasm that develops in the presence of KS‐associated herpesvirus (KSHV) and immune perturbation. In the current study, the authors compared CKS cases with age‐matched and sex‐matched KSHV‐seropositive controls without human immunodeficiency virus‐1 infection and markers of viral control, blood counts, CD4‐positive and CD8‐positive lymphocytes, and serum β‐2‐microglobulin and neopterin levels.

[1]  J. Goedert,et al.  Associations of Classic Kaposi Sarcoma with Common Variants in Genes that Modulate Host Immunity , 2006, Cancer Epidemiology Biomarkers & Prevention.

[2]  J. Goedert,et al.  Host immunogenetics and control of human herpesvirus-8 infection. , 2006, The Journal of infectious diseases.

[3]  A. Hatzakis,et al.  Association of clinical progression in classic Kaposi's sarcoma with reduction of peripheral B lymphocytes and partial increase in serum immune activation markers. , 2005, Archives of dermatology.

[4]  J. Goedert,et al.  A Common Genetic Variant in FCGR3A-V158F and Risk of Kaposi Sarcoma Herpesvirus Infection and Classic Kaposi Sarcoma , 2005, Cancer Epidemiology Biomarkers & Prevention.

[5]  J. Goedert,et al.  Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma , 2003, AIDS.

[6]  P. Pellett,et al.  Risk factors for Kaposi's sarcoma in men seropositive for both human herpesvirus 8 and human immunodeficiency virus , 2003, AIDS.

[7]  J. Goedert,et al.  Risk factors for classical Kaposi's sarcoma. , 2002, Journal of the National Cancer Institute.

[8]  J. Goedert,et al.  Prevalence of Kaposi's sarcoma‐associated herpesvirus infection in sex workers and women from the general population in Spain , 2002, International journal of cancer.

[9]  A. Blauvelt,et al.  Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus. , 2001, Blood.

[10]  W. Miley,et al.  A quantification of human cells using an ERV-3 real time PCR assay. , 2001, Journal of virological methods.

[11]  E. Cesarman,et al.  Viral G Protein–Coupled Receptor and Kaposi's Sarcoma , 2000, The Journal of experimental medicine.

[12]  D. Trichopoulos,et al.  The role of immunosuppression and immune‐activation in classic Kaposi's sarcoma , 1999, International journal of cancer.

[13]  P. Monini,et al.  Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma. , 1999, Blood.

[14]  G. Fadda,et al.  Human herpesvirus 8 in Italian HIV-seronegative patients with Kaposi sarcoma. , 1998, Archives of dermatology.

[15]  C. Boshoff,et al.  Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy. , 1998, Journal of the National Cancer Institute.

[16]  B. Ensoli,et al.  Kaposi's sarcoma pathogenesis: a link between immunology and tumor biology. , 1998, Critical reviews in oncogenesis.

[17]  A. Al-Khader,et al.  Kaposi's sarcoma in renal transplant recipients. , 1997, Annals of transplantation.

[18]  A. Haase,et al.  Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells , 1997, Journal of virology.

[19]  E. Tschachler,et al.  Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma. , 1996, The American journal of pathology.

[20]  G. Collina,et al.  Frequency and distribution of herpesvirus‐like DNA sequences (KSHV) in different stages of classic Kaposi's sarcoma and in normal tissues from an Italian population , 1996, International journal of cancer.

[21]  D R Hoover,et al.  Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma , 1996, AIDS.

[22]  C. Boshoff,et al.  Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma , 1995, The Lancet.

[23]  P. Hofschneider,et al.  Identification of interleukin-1 and platelet-derived growth factor-B as major mitogens for the spindle cells of Kaposi's sarcoma: a combined in vitro and in vivo analysis. , 1995, Oncogene.

[24]  P. Moore,et al.  Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. , 1995, The New England journal of medicine.

[25]  E. Cesarman,et al.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. , 1994, Science.

[26]  Altug Mh,et al.  Kaposi's sarcoma in renal transplant recipients. , 1994 .

[27]  M. Offermann,et al.  Induction of IL-6 gene expression in Kaposi's sarcoma cells. , 1994, Journal of immunology.

[28]  C. Ponticelli,et al.  Kaposi's sarcoma in kidney transplant recipients. , 1993, Archives of dermatology.

[29]  L. Buonaguro,et al.  Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implications for AIDS-Kaposi's sarcoma pathogenesis. , 1992, Journal of immunology.

[30]  D. Birnbaum,et al.  Fibroblast growth factor gene expression in AIDS-Kaposi's sarcoma detected by in situ hybridization. , 1991, The American journal of pathology.

[31]  T. Hirano,et al.  AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[32]  G. Melillo,et al.  Urinary neopterin and immunological features in patients with Kaposi's sarcoma. , 1988, European journal of cancer & clinical oncology.

[33]  JohnJ. Brooks.  KAPOSI'S SARCOMA: A REVERSIBLE HYPERPLASIA , 1986, The Lancet.

[34]  F. Real,et al.  Steroid-related development of Kaposi's sarcoma in a homosexual man with Burkitt's lymphoma. , 1986, The American journal of medicine.

[35]  Krown Se,et al.  Spontaneous regression of Kaposi's sarcoma in patients with AIDS. , 1985 .

[36]  R. Purcell,et al.  IgM antibody to hepatitis B core antigen: a marker of infectivity. , 1985, The New England journal of medicine.

[37]  P. Piot,et al.  Endemic african kaposi's sarcoma is not associated with immunodeficiency , 1985, International journal of cancer.

[38]  I. Schiff,et al.  Spontaneously healing Kaposi's sarcoma in AIDS. , 1985 .

[39]  V. Boneschi,et al.  Immunologic and immunogenetic features of primary Kaposi's sarcoma , 1985, Cancer.

[40]  G. Wood,et al.  Evidence for the origin of Kaposi's sarcoma from lymphatic endothelium. , 1985, The American journal of pathology.

[41]  M. Janier,et al.  Spontaneously healing Kaposi's sarcoma in AIDS. , 1985, The New England journal of medicine.

[42]  F. Real,et al.  Spontaneous regression of Kaposi's sarcoma in patients with AIDS. , 1985, The New England journal of medicine.

[43]  M. Akhtar,et al.  Kaposi's sarcoma in renal transplant recipients ultrastructural and immunoperoxidase study of four cases , 1984, Cancer.

[44]  D. Trichopoulos,et al.  Mediterranean Kaposi's sarcoma: preliminary communication about 131 cases. , 1984, Bulletin de la Societe de pathologie exotique et de ses filiales.

[45]  J. Rosenfeld,et al.  Kaposi sarcoma in kidney transplant recipients. , 1974, Archives of internal medicine.

[46]  Baig Ar,et al.  Sex-chromatin values in rat epithelium. , 1967 .